Bachem (BANB.SW)

Bachem stock price today, ATLAS forecast and fair value

Healthcare · Biotechnology · SIX Swiss Exchange · Switzerland

CHF 83.35▲ +0.60%

Prices as of Oct 27, 2026 · CHF

ATLAS fair value

CHF 38.27

Above fair value · 118% premium

Chance of rising in 1 month

51%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Bachem in ATLAS

ATLAS's own quantitative analysis, all in one place.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
See everything included
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.

On Bachem

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.

And for you

  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.
Get started →

Plans from €3.99 a month.

ATLAS estimates Bachem's fair value at about CHF 38.27 per share (reasonable range: CHF 25.73 to CHF 56.37). At CHF 83.35, the stock trades 118% above it.

It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Bachem a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between CHF 79.38 and CHF 87.90; in 9 out of 10, between CHF 72.52 and CHF 96.22. Estimated annual volatility is 26%.

Price, last 12 months (weekly close)

Bachem (BANB.SW) — Price, last 12 months (weekly close)Oct 24, 2025: CHF 57.35. Oct 27, 2026: CHF 83.35. ▲Fair value CHF 38.27CHF 84.15CHF 49.44Oct 24, 2025Oct 27, 2026

Key numbers

Market cap
CHF 6.2B
Market cap (USD)
$7.5B
P/E ratio
42.5
Dividend yield
1.05%
52-week high
CHF 86.00
52-week low
CHF 48.52
Revenue (12 months)
CHF 709M
Gross margin
27.0%
Operating margin
16.6%
Net margin
21.0%
Beta
0.79

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Bachem sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks BANB.SW has traded between CHF 48.52 and CHF 86.00. Today it is 3.1% below that high and 72% above its low.

On the business: net margin is 21.0%; it trades at 42.5 times earnings.

Its beta is 0.79: it tends to move less than the market.

About the company

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

Want to see everything about Bachem?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Bachem (BANB.SW) fair value?

About CHF 38.27 per share according to ATLAS (reasonable range: CHF 25.73 to CHF 56.37). With the stock at CHF 83.35, it is 118% above it.

What is the chance BANB.SW goes up next month?

51%: close to a coin flip. In half of the simulated outcomes, BANB.SW ends the month between CHF 79.38 and CHF 87.90.

How big is Bachem and what is its P/E ratio?

Bachem's market capitalization is CHF 6.2B. Its price-to-earnings (P/E) ratio is 42.5: you pay CHF 42.5 for each CHF 1.00 of yearly earnings.

Does Bachem pay a dividend?

Yes. BANB.SW's current dividend yield is 1.05% at today's price (CHF 83.35).

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy